Literature DB >> 16387828

Coronary flow reserve is preserved in white-coat hypertension.

D Erdogan1, H Gullu, M Caliskan, I Yildirim, D Tok, H Muderrisoglu.   

Abstract

OBJECTIVES: To assess the possible influence of white-coat hypertension (WCH) on coronary flow reserve (CFR).
METHODS: CFR was measured by means of transthoracic second harmonic Doppler echocardiography in 29 patients with WCH, 32 patients with sustained hypertension and 35 healthy volunteers.
RESULTS: CFR was significantly lower in the sustained hypertension group than in the WCH and the control groups, but it was not different between the WCH and the control groups (2.40 (SD 0.54), 2.77 (0.41) and 2.83 (0.60), respectively).
CONCLUSION: CFR is preserved in patients with WCH.

Entities:  

Mesh:

Year:  2005        PMID: 16387828      PMCID: PMC1861085          DOI: 10.1136/hrt.2005.074914

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  20 in total

1.  Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: a noninvasive, rapid and effective method for coronary flow reserve assessment.

Authors:  C Caiati; N Zedda; C Montaldo; R Montisci; S Iliceto
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

2.  Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy.

Authors:  I Antony; A Nitenberg; J M Foult; E Aptecar
Journal:  J Am Coll Cardiol       Date:  1993-08       Impact factor: 24.094

3.  Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension.

Authors:  Maurizio Galderisi; Silvana Cicala; Pio Caso; Luigi De Simone; Arcangelo D'Errico; Antonio Petrocelli; Oreste de Divitiis
Journal:  Am J Cardiol       Date:  2002-10-15       Impact factor: 2.778

4.  Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass.

Authors:  Maurizio Galderisi; Giovanni de Simone; Silvana Cicala; Luigi De Simone; Arcangelo D'Errico; Pio Caso; Oreste de Divitiis
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Authors: 
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

7.  Endothelial function in sustained and white coat hypertension.

Authors:  Sante D Pierdomenico; Francesco Cipollone; Domenico Lapenna; Anna Bucci; Franco Cuccurullo; Andrea Mezzetti
Journal:  Am J Hypertens       Date:  2002-11       Impact factor: 2.689

8.  Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique.

Authors:  T Hozumi; K Yoshida; T Akasaka; Y Asami; Y Ogata; T Takagi; S Kaji; T Kawamoto; Y Ueda; S Morioka
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

9.  Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle.

Authors:  A Polese; N De Cesare; P Montorsi; F Fabbiocchi; M Guazzi; A Loaldi; M D Guazzi
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

10.  Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension.

Authors:  C Cardillo; F De Felice; U Campia; G Folli
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

View more
  1 in total

1.  Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy.

Authors:  Dogan Erdogan; Hakan Gullu; Mustafa Caliskan; Ozgur Ciftci; Semra Baycan; Aylin Yildirir; Haldun Muderrisoglu
Journal:  Heart       Date:  2006-10-25       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.